Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q4 2020 Earnings

29MarExpected
Q1 2020
Q2 2020
Q3 2020
Q4 2020
-31.5
-21.21
-10.92
-0.63

Details

Expected EPS
-22.25
Actual EPS
-21.5
Surprise EPS
0.75
Surprise Percent
+3.37%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -21.5 per share for Q4 2020.

0 Comments

Share your thoughts